Atrium Therapeutics Reports Second Quarter 2026 Financial Results
Go back to Atrium Therapeutics Reports Second Quarter 2026 Financial Results| PROSENSA HOLD (NASDAQ: RNA) | Delayed: 7.84 -0.3 (3.69%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.14 | 52 Week High | $22.80 | |||
| Open | $8.22 | 52 Week Low | $4.12 | |||
| Day High | $8.42 | P/E | N/A | |||
| Day Low | $7.68 | EPS | $0.00 | |||
| Volume | 533,806 | |||||
| PROSENSA HOLD (NASDAQ: RNA) | Delayed: 7.84 -0.3 (3.69%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.14 | 52 Week High | $22.80 | |||
| Open | $8.22 | 52 Week Low | $4.12 | |||
| Day High | $8.42 | P/E | N/A | |||
| Day Low | $7.68 | EPS | $0.00 | |||
| Volume | 533,806 | |||||

